{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:01:10Z","timestamp":1790197270706,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020473","name":"Kemenristek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006456","name":"Bundesministerium f\u00fcr Wirtschaftliche Zusammenarbeit und Entwicklung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Zeitschrift f\u00fcr Medizinische Physik"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.zemedi.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:32:41Z","timestamp":1789471961000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-time-point renal TIA estimation, sparse SPECT\/CT data, and nonlinear mixed-effects modelling in [177Lu]Lu-PSMA-617 therapy"],"prefix":"10.1016","author":[{"given":"Fira Dwi","family":"Ananda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-8967","authenticated-orcid":false,"given":"Deni","family":"Hardiansyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-5620","authenticated-orcid":false,"given":"Rien","family":"Ritawidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambros J.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-1998","authenticated-orcid":false,"given":"Ludovic","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4133-3007","authenticated-orcid":false,"given":"Nicolas","family":"Varmenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-1576","authenticated-orcid":false,"given":"Gerhard","family":"Glatting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.zemedi.2026.09.001_b0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jmrs.227","article-title":"Lutetium 177PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy","volume":"64","author":"Emmett","year":"2017","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.zemedi.2026.09.001_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2967\/jnumed.116.183194","article-title":"German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients","volume":"58","author":"Rahbar","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2967\/jnumed.119.236414","article-title":"Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer","volume":"61","author":"Violet","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.zemedi.2026.09.001_b0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for Metastatic Castration-Resistant Prostate Cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0030","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00259-023-06255-8","article-title":"Joint EANM\/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)","volume":"50","author":"Kratochwil","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0035","doi-asserted-by":"crossref","unstructured":"Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry\u2014Standardization of Nomenclature. J Nucl Med 2009;50:477\u201384. doi: 10.2967\/jnumed.108.056036.","DOI":"10.2967\/jnumed.108.056036"},{"key":"10.1016\/j.zemedi.2026.09.001_b0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00259-010-1549-3","article-title":"EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting","volume":"38","author":"Lassmann","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.zemedi.2013.03.005","article-title":"Treatment planning in molecular radiotherapy","volume":"23","author":"Glatting","year":"2013","journal-title":"Z F\u00fcr Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00259-015-3248-6","article-title":"The role of patient-based treatment planning in peptide receptor radionuclide therapy","volume":"43","author":"Hardiansyah","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2967\/jnumed.117.193706","article-title":"Dose Mapping After Endoradiotherapy with 177Lu-DOTATATE\/DOTATOC by a Single Measurement After 4 Days","volume":"59","author":"H\u00e4nscheid","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40658-024-00658-8","article-title":"A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?","volume":"11","author":"Vergnaud","year":"2024","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40658-022-00462-2","article-title":"Patient-specific dosimetry adapted to variable number of SPECT\/CT time-points per cycle for 177Lu-DOTATATE therapy","volume":"9","author":"Vergnaud","year":"2022","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13550-023-00952-z","article-title":"Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation","volume":"13","author":"Peters","year":"2023","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.zemedi.2026.09.001_b0075","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2967\/jnumed.123.266871","article-title":"Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177 Lu]Lu-PSMA-I&T Therapy","volume":"65","author":"Resch","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103192","article-title":"Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls","volume":"117","author":"Ivashchenko","year":"2024","journal-title":"Phys Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0085","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2967\/jnumed.123.266268","article-title":"Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [177Lu]Lu-PSMA-617 Therapy","volume":"65","author":"Hardiansyah","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40658-023-00530-1","article-title":"Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept","volume":"10","author":"Hardiansyah","year":"2023","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0095","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2967\/jnumed.124.268175","article-title":"Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning","volume":"66","author":"Gomes","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40658-021-00427-x","article-title":"A population-based method to determine the time-integrated activity in molecular radiotherapy","volume":"8","author":"Hardiansyah","year":"2021","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.zemedi.2023.01.007","article-title":"Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling","volume":"34","author":"Hardiansyah","year":"2024","journal-title":"Z F\u00fcr Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0110","unstructured":"European Medicines Agency. Guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population 2006."},{"key":"10.1016\/j.zemedi.2026.09.001_b0115","unstructured":"European Medicines Agency. Guideline On Reporting The Results Of Population Pharmacokinetic Analyses. EMA 2007 n.d."},{"key":"10.1016\/j.zemedi.2026.09.001_b0120","unstructured":"Babar Z ud D. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. San Diego: Elsevier Science & Technology; 2019."},{"key":"10.1016\/j.zemedi.2026.09.001_b0125","unstructured":"Brum L. Population Pharmacokinetics \u2014 Guidance for Industry. US Dep Health Hum Serv Food Drug Adm Cent Drug Eval Res CDER Cent Biol Eval Res CBER 2022."},{"key":"10.1016\/j.zemedi.2026.09.001_b0130","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease 2024;105:S117\u2013314. doi: 10.1016\/j.kint.2023.10.018.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"10.1016\/j.zemedi.2026.09.001_b0135","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00259-022-05727-7","article-title":"EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands","volume":"49","author":"Sj\u00f6green Gleisner","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0140","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0145","article-title":"Total Segmentator: Robust Segmentation of 104 Anatomic Structures in CT Images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/j.zemedi.2026.09.001_b0150","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2967\/jnumed.119.240366","article-title":"OpenDose: Open-Access Resource for Nuclear Medicine Dosimetry","volume":"61","author":"Chauvin","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2019.100514","article-title":"Nuclear Data Sheets for A=177","volume":"159","author":"Kondev","year":"2019","journal-title":"Nucl Data Sheets"},{"key":"10.1016\/j.zemedi.2026.09.001_b0160","doi-asserted-by":"crossref","unstructured":"Burnham KP, Anderson DR, editors. Model Selection and Multimodel Inference. New York, NY: Springer New York; 2004. doi: 10.1007\/b97636.","DOI":"10.1007\/b97636"},{"key":"10.1016\/j.zemedi.2026.09.001_b0165","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1118\/1.597421","article-title":"On the correction for radioactive decay in pharmacokinetic modeling","volume":"22","author":"Williams","year":"1995","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0170","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1118\/1.598561","article-title":"Treatment of radioactive decay in pharmacokinetic modeling: Influence on parameter estimation in cardiac 13N-PET","volume":"26","author":"Glatting","year":"1999","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmpb.2004.01.001","article-title":"Non-linear mixed-effects pharmacokinetic\/pharmacodynamic modelling in NLME using differential equations","volume":"76","author":"Torn\u00f8e","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.zemedi.2026.09.001_b0180","doi-asserted-by":"crossref","unstructured":"Owen JS, Fiedler\u2010Kelly J. Introduction to Population Pharmacokinetic \/ Pharmacodynamic Analysis with Nonlinear Mixed Effects Models. 1st ed. Wiley; 2014. doi: 10.1002\/9781118784860.","DOI":"10.1002\/9781118784860"},{"key":"10.1016\/j.zemedi.2026.09.001_b0185","doi-asserted-by":"crossref","unstructured":"Davidian M, Giltinan DM. Nonlinear Models for Repeated Measurement Data. 1st ed. Routledge; 2017. doi: 10.1201\/9780203745502.","DOI":"10.1201\/9780203745502-1"},{"key":"10.1016\/j.zemedi.2026.09.001_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2012.4","article-title":"Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"10.1016\/j.zemedi.2026.09.001_b0195","doi-asserted-by":"crossref","unstructured":"Bonate PL. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. Boston, MA: Springer US; 2011. doi: 10.1007\/978-1-4419-9485-1.","DOI":"10.1007\/978-1-4419-9485-1"},{"key":"10.1016\/j.zemedi.2026.09.001_b0200","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/psp4.12422","article-title":"NONMEM Tutorial Part II: Estimation Methods and Advanced Examples","volume":"8","author":"Bauer","year":"2019","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"10.1016\/j.zemedi.2026.09.001_b0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.zemedi.2009.05.003","article-title":"Model selection for time-activity curves: The corrected Akaike information criterion and the F-test","volume":"19","author":"Kletting","year":"2009","journal-title":"Z F\u00fcr Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0210","doi-asserted-by":"crossref","DOI":"10.1118\/1.4820367","article-title":"Molecular radiotherapy: The NUKFIT software for calculating the time-integrated activity coefficient","volume":"40","author":"Kletting","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0215","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/psp4.12404","article-title":"NONMEM Tutorial Part I: Description of Commands and Options, With Simple Examples of Population Analysis","volume":"8","author":"Bauer","year":"2019","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"10.1016\/j.zemedi.2026.09.001_b0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1208\/s12248-025-01065-2","article-title":"The Reference-Corrected Visual Predictive Check: A More Intuitive Diagnostic for Non-Linear Mixed Effects Models","volume":"27","author":"Ibrahim","year":"2025","journal-title":"AAPS J"},{"key":"10.1016\/j.zemedi.2026.09.001_b0225","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2307\/3803117","article-title":"Model Selection and Inference: A Practical Information-Theoretic Approach","volume":"65","author":"Beier","year":"2001","journal-title":"J Wildl Manag"},{"key":"10.1016\/j.zemedi.2026.09.001_b0230","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1118\/1.2794176","article-title":"Choosing the optimal fit function: Comparison of the Akaike information criterion and the F-test","volume":"34","author":"Glatting","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.23876\/j.krcp.25.046","article-title":"Statistical consideration in nephrology research","volume":"44","author":"Xu","year":"2025","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.zemedi.2026.09.001_b0240","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13318-018-0484-8","article-title":"Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM\u00ae Across Rich, Medium, and Sparse Sampling Data","volume":"43","author":"Sukarnjanaset","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.zemedi.2026.09.001_b0245","article-title":"Mixed Effects Models for the Population Approach","author":"Lavielle","year":"2014","journal-title":"Chapman and Hall\/CRC"},{"key":"10.1016\/j.zemedi.2026.09.001_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/mp.70212","article-title":"Accuracy and precision of few-time-points renal dosimetry for [177 Lu]Lu-PSMA-617 therapy: Analysis with nonlinear mixed-effects modeling","volume":"53","author":"Hakim","year":"2026","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0255","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mp.12886","article-title":"Technical Note: Single time point dose estimate for exponential clearance","volume":"45","author":"Madsen","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0260","doi-asserted-by":"crossref","unstructured":"INTERNATIONAL ATOMIC ENERGY AGENCY. Absorbed Dose Determination in External Beam Radiotherapy. Rev. 1. INTERNATIONAL ATOMIC ENERGY AGENCY; 2024. doi: 10.61092\/iaea.ve7q-y94k.","DOI":"10.61092\/iaea.ve7q-y94k"},{"key":"10.1016\/j.zemedi.2026.09.001_b0265","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00259-018-4136-7","article-title":"EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations","volume":"45","author":"Gear","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0270","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1625927","article-title":"Dosimetry with 188Re-labelled monoclonal anti-CD66 antibodies: A simplified approach based on a single measurement 3 h p. i","volume":"45","author":"Glatting","year":"2006","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.zemedi.2026.09.001_b0275","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1007\/s00259-019-04485-3","article-title":"EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)","volume":"46","author":"Kratochwil","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0280","doi-asserted-by":"crossref","DOI":"10.1002\/mp.70000","article-title":"Single-time-point tumor dosimetry using population-based model selection and nonlinear mixed-effects modeling in [177Lu]Lu-PSMA-617 therapy","volume":"52","author":"Hardiansyah","year":"2025","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.09.001_b0285","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.2967\/jnumed.121.262748","article-title":"An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 1: Design and Early Results of the SNMMI Dosimetry Challenge","volume":"62","author":"Uribe","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.zemedi.2026.09.001_b0290","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2025.05.014","article-title":"Machine Learning-based Dose Prediction in [177Lu]Lu-PSMA-617 Therapy by Integrating Biomarkers and Radiomic Features from [68Ga]Ga-PSMA-11 Positron Emission Tomography\/Computed Tomography","volume":"123","author":"Yazdani","year":"2025","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.zemedi.2026.09.001_b0295","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00259-025-07612-5","article-title":"Critical review of partial volume correction methods in PET and SPECT imaging: benefits, pitfalls, challenges, and future outlook","volume":"53","author":"Azimi","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.09.001_b0300","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2967\/jnumed.125.270170","article-title":"Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy","volume":"66","author":"Grkovski","year":"2025","journal-title":"J Nucl Med"}],"container-title":["Zeitschrift f\u00fcr Medizinische Physik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939388926000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939388926000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:02:38Z","timestamp":1790193758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939388926000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"alternative-id":["S0939388926000942"],"URL":"https:\/\/doi.org\/10.1016\/j.zemedi.2026.09.001","relation":{},"ISSN":["0939-3889"],"issn-type":[{"value":"0939-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-time-point renal TIA estimation, sparse SPECT\/CT data, and nonlinear mixed-effects modelling in [177Lu]Lu-PSMA-617 therapy","name":"articletitle","label":"Article Title"},{"value":"Zeitschrift f\u00fcr Medizinische Physik","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.zemedi.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH on behalf of DGMP, \u00d6GMP and SSRMP.","name":"copyright","label":"Copyright"}]}}